Literature DB >> 24777098

Emergence of high-level azithromycin resistance in Campylobacter jejuni isolates from pediatric diarrhea patients in Kolkata, India.

Piyali Mukherjee1, T Ramamurthy1, Utpala Mitra1, Asish K Mukhopadhyay2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24777098      PMCID： PMC4068546          DOI： 10.1128/AAC.02931-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

Review 1.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Amera Gibreel; Diane E Taylor
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

2.  Campylobacter species and drug resistance in a north Indian rural community.

Authors:  Deepika Jain; Sushmita Sinha; Kashi N Prasad; Chandra M Pandey
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-03       Impact factor: 2.184

3.  Increasing antimicrobial resistance of campylobacter jejuni isolated from paediatric diarrhea cases in a tertiary care hospital of new delhi, India.

Authors:  Roumi Ghosh; Beena Uppal; Prabhav Aggarwal; Anita Chakravarti; Arun Kumar Jha
Journal:  J Clin Diagn Res       Date:  2013-01-11

4.  Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni.

Authors:  Yassir A Almofti; Menghong Dai; Yawei Sun; Hao Haihong; Zonghui Yuan
Journal:  Microb Pathog       Date:  2011-03-04       Impact factor: 3.738

5.  Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole.

Authors:  J Y Jeong; A K Mukhopadhyay; J K Akada; D Dailidiene; P S Hoffman; D E Berg
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp.

Authors:  Sylvie Vacher; Armelle Ménard; Elisabeth Bernard; Francis Mégraud
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

7.  23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni.

Authors:  Haihong Hao; Menghong Dai; Yulian Wang; Dapeng Peng; Zhenli Liu; Zonghui Yuan
Journal:  Microb Drug Resist       Date:  2009-12       Impact factor: 3.431

8.  Campylobacter jejuni in hospitalized patients with diarrhea, Kolkata, India.

Authors:  Piyali Mukherjee; T Ramamurthy; Mihir K Bhattacharya; K Rajendran; Asish K Mukhopadhyay
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883
  8 in total
  5 in total

Review 1.  Update on the burden of Campylobacter in developing countries.

Authors:  James A Platts-Mills; Margaret Kosek
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

2.  Predictors of rational management of diarrhea in an endemic setting: observation from India.

Authors:  Tanmay Mahapatra; Sanchita Mahapatra; Barnali Banerjee; Umakanta Mahapatra; Sandip Samanta; Debottam Pal; Nandini Datta Chakraborty; Byomkesh Manna; Dipika Sur; Suman Kanungo
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

3.  Bibliometric analysis of publications on Campylobacter: (2000-2015).

Authors:  Waleed M Sweileh; Samah W Al-Jabi; Ansam F Sawalha; Adham S AbuTaha; Sa'ed H Zyoud
Journal:  J Health Popul Nutr       Date:  2016-11-29       Impact factor: 2.000

4.  Development and evaluation of a PCR assay for rapid detection of azithromycin resistant Campylobacter isolated from diarrhoeal patients in Kolkata, India.

Authors:  Piyali Mukherjee; Shanta Dutta; Asish K Mukhopadhyay
Journal:  Gut Pathog       Date:  2017-06-21       Impact factor: 4.181

5.  Risk of multi-drug resistant Campylobacter spp. and residual antimicrobials at poultry farms and live bird markets in Bangladesh.

Authors:  Sucharit Basu Neogi; Md Mehedul Islam; S K Shaheenur Islam; A H M Taslima Akhter; Md Mahmudul Hasan Sikder; Shinji Yamasaki; S M Lutful Kabir
Journal:  BMC Infect Dis       Date:  2020-04-15       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.